摘要
回顾2016年乳腺肿瘤学科的发展,精准医学热度依旧,基因测序、液体活组织检查等方面不断有新的研究成果问世。但同时,精准医学的发展并不顺利,大数据的建立与共享、基因检测标准化等问题依然制约着乳腺癌诊疗技术的发展,未来需要加强合作与共享,建立行业标准,加快新药研发,以及利用精准医学技术不断完善临床实践。
According to the review of breast cancer researches in 2016, precision medicine is still a hot topic, with new achievements in gene sequencing, liquid biopsy, etc. Meanwhile, the development of precision medicine is not always smooth. Some issues, including the establishment and sharing of large data, standardization of genetic testing, restrict the technological development of breast cancer diagnosis and treatment. In the future, researchers and physicians in this field should strengthen the cooperation and data- sharing, establish professional standards, speed up the development of new drugs and apply the technologies of precision medicine in order to improve clinical practice.
出处
《中华乳腺病杂志(电子版)》
CAS
CSCD
2017年第2期65-68,共4页
Chinese Journal of Breast Disease(Electronic Edition)
关键词
乳腺肿瘤
癌基因
DNA
肿瘤
血液循环
精准医学
大数据
Breast neoplasms
Oncogenes
DNA, neoplasm
Blood circulation
Precisionmedicine
Big data